3-Cyclopentylacrylonitrile

Catalog No.: 
ACFRPN346
CAS No.: 
591769-05-0
Molecular Formula: 
C8H11N
Molecular Weight: 
121.18
3-Cyclopentylacrylonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$69.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Cyclopentylacrylonitrile
IUPAC Name3-cyclopentylacrylonitrile
MDL No.MFCD11857755
Molecular FormulaC8H11N
Molecular Weight121.18
SMILESN#CC=CC1CCCC1
InChI KeyVMELXYJYSXXORF-UHFFFAOYSA-N
Synonym3-Cyclopentylacrylonitrile 97%;3-CYCLOPENTYLACRYLONITRILE;(E)-3-cyclopentylacrylonitrile;3-cyyclopentylacrylonitrile;3-cyclopentylprop-2-enenitrile;3-cyclopentyl-2-Propenenitrile;(E)-3-cyclopentylprop-2-enenitrile;2-Propenenitrile,3-cyclopentyl-
CAS No.591769-05-0
PubChem CID21427952

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301
Precautionary Statement(s)
P264-P270-P301+P310-P405-P501

Synthetic Route by SureRoute

1. ACFRPN346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUVYL473 route compound structure diagram
    ACUVYL47316640-68-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRPN346 route product structure diagram
    ACFRPN346591769-05-0In Stock
Inquiry

2. ACFRPN346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRPN346 route product structure diagram
    ACFRPN346591769-05-0In Stock
Inquiry

3. ACFRPN346 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRPN346 route product structure diagram
    ACFRPN346591769-05-0In Stock
Inquiry

Comments (0)